Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_assertion type Assertion NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_head.
- NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_provenance.
- NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_assertion evidence source_evidence_literature NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_provenance.
- NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_assertion SIO_000772 21289371 NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_provenance.
- NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_assertion wasDerivedFrom befree-20150227 NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_provenance.
- NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_assertion wasGeneratedBy ECO_0000203 NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_provenance.